Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Mental health platform fined $7M by FTC for sharing data with advertisers

Cerebral has admitted to improperly sharing data with social media platforms for the purpose of targeted advertising. The company also made it difficult to cancel the service, costing its members millions.

Healthcare worker sentenced to 10 years for abusing disabled patients

Tyler Smith and co-defendant Zachary Dinell confessed to assaulting more than a dozen patients, expressing hatred for them simply because they’re disabled.

Thumbnail

Health system employees win $200M lawsuit over unpaid wages

In a complaint first filed in 2021, the plaintiffs said not-for-profit Providence Health & Services used an illegal time-clock policy to steal owed pay of more than $98 million from workers over the course of several years.

Nurses gather at Kaiser hospital to protest rapid adoption of AI

The California Nurses Association said AI is largely unregulated, untested and poses a serious threat to patient safety.

bipartisan house task force on artificial intelligence

House to hold hearing on new patient data rights legislation

The bipartisan American Privacy Rights Act (APRA) would allow consumers to access and delete much of their personal data being held by private companies.

google cloud mayo clinic artificial intelligence

Doctors sue over negative Google reviews

The class action lawsuit was filed in Japan to raise public awareness about the state of Google reviews, many of which the plaintiffs claim are fake.

Money bankruptcy debt liquidation

Private equity bankruptcies in healthcare explode 112% in 5 years

According to the Private Equity Stakeholder Project, 21% of all healthcare bankruptcies in 2023 involved organizations owned by financial firms.

the words "FDA recall" on a board

Boston Scientific recalls premixed embolic agent after two deaths

There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower GI bleed embolization procedures.  

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup